A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients with Progressive Supranuclear Palsy Who Participated in Study CN002003

Project: Research project

Description

A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients with Progressive Supranuclear Palsy Who Participated in Study CN002003
StatusActive
Effective start/end date10/11/183/31/20

Funding

  • Biogen IDEC

Fingerprint

Progressive Supranuclear Palsy
Therapeutics